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Ochratoxin A (OTA) is a widespread mycotoxin of cereals and many agricultural products and causes
high incidences of renal tumors in rodents. Although its carcinogenic properties have been known since
the eighties, the precise mechanism of action is still relatively undefined. At present, increasing evidence
suggests that OTA does not act with a direct genotoxic mechanism, opposed to other previous evidence
where the formation of DNA adducts by 32P-postlabeling was observed. The genotoxic activity of OTA
assessed in a variety of in vitro and in vivo studies was very low if genotoxic at all. In this study, we
clearly show that OTA does not bear any clastogenic or aneugenic activity based on the absence of the
induction of chromosome aberrations, sister chromatid exchanges, and micronuclei in human lymphocytes
and V79 cells in vitro in both the absence and the presence of S9 metabolism. Alternatively, cytogenetic
analyses evidenced significant increases in endoreduplicated cells and highly condensed metaphases with
separated chromatids. This implies that OTA or its possible metabolites do not covalently bind DNA
through the formation of adducts since structural chromosome aberrations are a very sensitive end points
to detect chemical carcinogens with electrophilic substituents. Alternatively, induction of endoreduplication
and chromatid separation provides strong evidence for a DNA nonreactive mechanism of OTA
carcinogenicity involving the disruption of mitosis by interfering with key regulators of chromosome
separation and progression of mitosis. This causes a temporary arrest of mitoses and premature exit from
it (mitotic slippage) to generate endoreduplication and polyploidy accompanied by increased risk of
aneuploidy and subsequent tumor formation.
Introduction
Ochratoxin A (OTA)1 is a mycotoxin produced by several
species of fungi (Penicillium and Aspergillum species), and it
occurs naturally in cereal and grain products. OTA is a
nephrotoxic mycotoxin with strong carcinogenic properties to
rodents (1, 2) and possesses teratogenic, immunotoxic (3–5),
and possibly neurotoxic activities (6, 7). Furthermore, it has
been considered potentially responsible for the development of
nephropathies observed in different farm animals (8). In humans,
it is supposed to be associated with Balkan endemic nephropathy
(BEN) and is possibly involved in the origin of urinary tract
tumors (9). On these bases, OTA has been classified as a
possible human carcinogen by the International Agency for
Research on Cancer (IARC) (10). Since then, the carcinogenic
mechanism of OTA has still been relatively undefined, although
at present increasing evidence suggests that OTA does not act
with a direct genotoxic mechanism. This is supported by
different studies with radiolabeled OTA unable to detect any
DNA binding of OTA (11–14) as opposed to previous studies
using the 32P-postlabeling method in which DNA adducts were
reported (15–17), although the authors did not provide structural
information on the nature of the adduct. On the other hand, the
genotoxic activity of OTA assessed in a variety of in vitro and
in vivo studies was very low if genotoxic at all. OTA did not
prove to be mutagenic in Salmonella typhimurium in both the
absence and the presence of metabolic activation systems, when
assays were conducted according to standard protocols (2, 18–22),
although mutations after exposure to OTA were reported using
nonvalidated modifications of the Ames test (23). OTA was also
negative in a Salmonella microsome assay with a HepG2-
derived enzyme (S9 mix) with the TA98 and TA100 strains
(24) and in the Escherichia coli SOS spot test at nontoxic
concentrations (25–27). In mammalian cells, conflicting results
were obtained regarding the potential of OTA to induce
mutations. OTA was not mutagenic in thymidine kinase (TK()
mouse lymphoma cells or in the hypoxanthine-guanine phos-
phoribosyltransferase (HPRT) test system (19, 22). In contrast,
mutagenic effects of OTA were reported in NIH 3T3 mouse
fibroblasts stably transfected with human cytochrome P450s
(28), although these results are difficult to interpret since studies
on OTA metabolism indicate that bioactivation does not play a
role in OTA toxicity and carcinogenicity (11–13, 29, 30). In
Chinese hamster ovary (CHO) cells, chromosomal aberrations
were not seen after exposure to OTA, but only a small increase
in the frequency of sister chromatid exchanges (SCEs) was noted
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